Journal of Peking University (Health Sciences) ›› 2023, Vol. 55 ›› Issue (4): 748-754. doi: 10.19723/j.issn.1671-167X.2023.04.029

Previous Articles     Next Articles

Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report

Jie QIAO,Li-xia LU,Yu-ting HE,Chun-cui MEN,Xin-xin CHU,Bei WU,Hui-ping ZHAO*(),Mei WANG   

  1. Department of Nephrology, Peking University People's Hospital, Beijing 100044, China
  • Received:2021-11-10 Online:2023-08-18 Published:2023-08-03
  • Contact: Hui-ping ZHAO E-mail:huipingzhao2009@163.com
  • Supported by:
    Research and Development Fund of People's Hospital of Peking University(RDN 2013-02)

RICH HTML

  

Abstract:

Peritoneal dialysis (PD) catheter-related infection (i.e. exit-site infection and tunnel infection) is one of the main causes of PD-related peritonitis. If it cannot be controlled effectively, it could lead to PD technique failure. Therefore, timely and effective diagnosis and treatment and active prevention so as to reduce PD catheter-related infection is an important treatment goal in PD patients. PD catheter exit-site infection (ESI) and tunnel infection can be caused by a variety of microorganisms, mainly bacteria, while fungi are very rare. Few public data can be used to guide treatment of PD catheter-related fungal infection, and there is no related report in China till now. Once fungal peritonitis occurred, the patient can only withdraw from PD treatment. Here, we report a case of fungal PD catheter ESI combined with tunnel infection which was successfully diagnosed and treated in our PD center. A 71-year-old woman came to clinic because of "PD for 5 years, secretions from exit site for 8 days and aggravation for 1 day". The patient suffered from peritonitis, ESI and tunnel infection for many times in the past 5 years, involving a variety of pathogens. Eight days before, she found white viscous discharge from exit site. The subcutaneous cuff completely came out of it and rubbed its skin. The Schaefer exit-site score was 3 points. Due to the suspected ESI 2 months before, the discharge swab for bacterial culture was positive for Pseudomonas aeruginosa, so the exit site swab for bacterial culture was done again, and gentamicin injection was applied topically once a day for empirical treatment. The exit site was evaluated one day before: The subcutaneous tunnel was significantly swollen and slightly tender at 2.5 cm away from the exit site, and with white medium amount of viscous secretions. The exit-site score increased to 4 points. Routine test of dialysis effluent was (-). The bacterial culture of the exit-site discharge was rechecked twice, and Candida parapsilosis was positive for two times, so the diagnosis of fungal PD catheter ESI combined with tunnel infection was clear. Immediately we searched for the causes of ESI and tunnel infection. We found that the patient had a suspicious history of gray toenail on the foot. The toenail smear was positive for fungi and visible hyphae. She washed feet with hands every day, and washed clothes on a low bench every day, which made the exit-site and tunnel squeezed for a long time. Based on the above causes, we gave her comprehensive treatment as follows: For ESI and tunnel fungal infections, fluco-nazole was used systemically according to the drug sensitivity results, and miconazole cream was applied to the exit-site locally. For the subcutaneous cuff that came out completely, daily iodophor disinfection was given locally. At the same time, local antifungal treatment was given to the foot. We followed up closely during treatment, evaluated the exit-site every 2-3 days, and took photos of the exit-site to dynamically observe the effect. After 14 days of treatment, the exit-site score continued to be 0-1, the bacterial culture of the exit-site was negative, the cuff culture was negative, and the tunnel B-ultrasound was normal. The patient had been followed up regularly once a month for 60 months, no ESI and tunnel infection occurred. Fungal PD catheter ESI and tunnel infection are rare complications of PD. When the standard anti-infection treatment is ineffective, the possibility of fungal infection should be considered, so as to avoid prolonged use of antibiotics, aggravating fungal infection, and even progressing to fungal peritonitis, leading to withdrawal from PD. Accurate exit-site evaluation is helpful for timely diagnosis and early treatment of ESI and tunnel infection. The exit-site discharge culture and drug sensitivity test before treatment are helpful to identify the pathogen and adjust subsequent treatment. At the same time, repeated discharge culture is required in order to exclude positive fungal culture results caused by contamination. Once fungal catheter-related infection is diagnosed, we should search for possible causes actively, subsequent targeted and comprehensive treatment plays a decisive role for the prognosis of patients.

Key words: Peritoneal dialysis, Exit-site infection, Tunnel infection, Fungus

CLC Number: 

  • R459.5

Table 1

Summary of previous peritoneal dialysis related infections in the patient"

No. PD duration/
months
PD-related
infection
Schaefer
exit-site
score
Bacterial culture Tunnel
B-ultrasound
Cause Treatment and outcome
1 23 Peritonitis 0 point Staphylococcus warneri Not done Improper PD exchange operation Cefazolin 1.0 g+ceftriaxone 1.0 g, qd, IP for 2 weeks, cured
2 37 ESI and tunnel infection 5 points Enterobacter cloacae Indicate infection The button on the self-made abdominal strap was squeezed Diluted iodophor+ mupirocin qd used locally; Cefuroxime 0.25 g bid oral for 2 weeks, cured
3 40 ESI and tunnel infection 5 points Actinomyces (medium) Indicate infection The distance between the subcutaneous cuff and the exit-site < 1 cm; Tunnel was compressed Diluted iodophor+ mupirocin qd used locally; Cefuroxime 0.25 g bid oral for 2 weeks, cured
4 52 Peritonitis 0 point Bacillus cereus Not done Constipation, improper PD exchange operation Cefazolin 1.0 g+ceftriaxone 1.0 g, qd, IP for 3 weeks, cured
5 53 Tunnel infection 4 points Culture negative Indicate infection Subcutaneous cuff half came out; Use a towel to wrap around her waist when sleeping and the tunnel was squeezed Mupirocin qd used locally; Cefuroxime 0.25 g bid orally for 2 weeks, cured
6 55 Suspected ESI 2 points Pseudomonas aeruginosa Not done Subcutaneous cuff completely came out of the exit site and rubbed the skin Mupirocin qd used locally; Cefuroxime 0.25 g bid oral for 2 weeks, cured
7 57 Suspected ESI 2 points Pseudomonas aeruginosa (small amount)Hemolytic staphylococcus (small amount) Not done Subcutaneous cuff completely came out and rubbed the skin Mupirocin qd used locally; Levofloxacin 0.2 g qd oral for 2 weeks, cured
8 58
(2 months
before this
visit)
Suspected ESI 3 points Pseudomonas aeruginosa (small amount) Not done Subcutaneous cuff completely came out and rubbed the skin Gentamicin 2 mL qd externally for 3 weeks, cured

Figure 1

Comparison of patient's exit-site infection complicated with tunnel infection A, before treatment, significant swelling in the tunnel with white discharge at the exit-site, and the exit-site score was 4 points; B, after 2 days of treatment, there was an increase in secretions, and the exit-site score was 4 points; C, after 14 days of treatment, the exit-site score was 0."

Table 2

Evaluation of the exit-site in the patient with fungal exit-site infection and tunnel infection before and after treatment"

Time Exit-site evaluation Tunnel evaluation Schaefer
exit-site
score
Tunnel B-ultrasound
Day0
    (the day of begining
    antifungal treatment)
White, medium amount of viscous secretions At a distance of 2.5 cm from the exit-site in the tunnel, tenderness (+), and the range of tunnel redness and swelling was 4 cm×2.5 cm 4 points Low echo surrounding the catheter near the exit-site, considering infection changes
Day2
    (after antifungal treatment)
Chartreuse, medium amount of viscous secretions At a distance of 1.5 cm from the exit-site in the tunnel, tenderness (+), and the range of tunnel redness and swelling was 4 cm×1.5 cm 4 points Considering tunnel infection
Day3 Chartreuse, small amount of secretion, locally dry No tenderness in the tunnel, with the range of redness and swelling was 2 cm×1 cm 2 points -
Day4 Very little chartreuse secretion, locally dry No tenderness in the tunnel, with the swelling range of 1 cm×1 cm 2 points -
Day5 No discharge No tenderness or swelling in the tunnel 0 point -
Day7-Day14 No discharge No tenderness or swelling in the tunnel 0 point Normal

Figure 2

Summary of the diagnosis and treatment process in the patient with fungal exit-site infection and tunnel infection ESS, exit-site score; gd, once a day; PD, peritoneal dialysis; IP, intraperitoneal; w1d, once a week."

1 Szeto CC , Li PK , Johnson DW , et al. ISPD catheter-related infection recommendations: 2017 update[J]. Perit Dial Int, 2017, 37 (2): 141- 154.
doi: 10.3747/pdi.2016.00120
2 Meng C , Beco A , Oliveira A , et al. Peritoneal dialysis cuff-shaving: A salvage therapy for refractory exit-site infections[J]. Perit Dial Int, 2019, 39 (3): 276- 281.
doi: 10.3747/pdi.2018.00193
3 Jhawar MS , Das J , George P , et al. CAPD catheter exit-site and tunnel infection with fungal etiology-treatment and catheter reinsertion for an extremely rare complication[J]. Perit Dial Int, 2017, 37 (2): 237- 239.
doi: 10.3747/pdi.2016.00031
4 Schwetz I , Horina J , Buzina W , et al. Aspergillus oryzae peritonitis in CAPD: Case report and review of the literature[J]. Am J Kidney Dis, 2007, 49 (5): 701- 704.
doi: 10.1053/j.ajkd.2007.02.260
5 De Bernardis F , Mondello F , San Millan R , et al. Biotyping and virulence properties of skin isolates of Candida parapsilosis[J]. J Clin Microbiol, 1999, 37 (11): 3481- 3486.
doi: 10.1128/JCM.37.11.3481-3486.1999
6 Almirante B , Rodriguez D , Cuenca-Estrella M , et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis blood stream infections: Case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003[J]. J Clin Microbiol, 2006, 44 (5): 1681- 1685.
doi: 10.1128/JCM.44.5.1681-1685.2006
7 Branchini ML , Pfaller MA , Rhine-Chalberg J , et al. Genotypic variation and slime production among blood and catheter risolates of Candida parapsilosis[J]. J Clin Microbiol, 1994, 32 (2): 452- 456.
doi: 10.1128/jcm.32.2.452-456.1994
8 Pfaller MA , Diekema DJ . Epidemiology of invasive candidiasis: A persistent public health problem[J]. Clin Microbiol Rev, 2007, 20 (1): 133- 163.
doi: 10.1128/CMR.00029-06
9 Piraino B , Bailie GR , Bernardini J , et al. ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update[J]. Perit Dial Int, 2005, 25 (2): 107- 131.
doi: 10.1177/089686080502500203
10 Li PK , Szeto CC , Piraino B , et al. International society for peritoneal dialysis. Peritoneal dialysis-related infections recommendations: 2010 update[J]. Perit Dial Int, 2010, 30 (4): 393- 423.
doi: 10.3747/pdi.2010.00049
11 Schaefer F , Klaus G , Müller-Wiefel DE , et al. Intermittent versus continuous intraperitoneal glycopeptide /ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS)[J]. J Am Soc Nephrol, 1999, 10 (1): 136- 145.
doi: 10.1681/ASN.V101136
12 Swartz SJ , Neu A , Skversky Mason A , et al. Exit site and tunnel infections in children on chronic peritoneal dialysis: Findings from the standardizing care to improve outcomes in pediatric end stage renal disease (SCOPE) collaborative[J]. Pediatr Nephrol, 2018, 33 (6): 1029- 1035.
doi: 10.1007/s00467-018-3889-3
13 Bernardini J , Bender F , Florio T , et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients[J]. J Am Soc Nephrol, 2005, 16 (2): 539- 545.
doi: 10.1681/ASN.2004090773
14 Ramage G , Martinez JP , Lopez-Ribot JL . Candida biofilms on implanted biomaterials: A clinically significant problem[J]. FEMS Yeast Res, 2006, 6 (7): 979- 986.
doi: 10.1111/j.1567-1364.2006.00117.x
15 Prasad N , Gupta A . Fungal peritonitis in peritoneal dialysis patients[J]. Perit Dial Int, 2005, 25 (3): 207- 222.
doi: 10.1177/089686080502500302
16 Li PK , Szeto CC , Piraino B , et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment[J]. Perit Dial Int, 2016, 36 (5): 481- 508.
doi: 10.3747/pdi.2016.00078
[1] Wanyin HOU,Jie DONG. Acquired cystic kidney hemorrhage in peritoneal dialysis patients: A report of three cases [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 546-550.
[2] Wen TANG,Jun-yi GAO,Xin-yu MA,Chao-he ZHANG,Lian-tao MA,Ya-sha WANG. Application of recurrent neural network in prognosis of peritoneal dialysis [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 602-608.
[3] Li-ping DUAN,Zhao-xia ZHENG,Yu-hui ZHANG,Jie DONG. Association of malnutrition-inflammation-cardiovascular disease with cognitive deterioration in peritoneal dialysis patients [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 510-518.
[4] TSAI Shih-ming, YAN Yu, ZHAO Hui-ping, WU Bei, ZUO Li, WANG Mei. Peritoneal dialysis-related eosinophilic peritonitis: a case report and literature review [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 747-751.
[5] LI Xiang-you, WU Jun△, LUO Dan, CHEN Wan-xian, ZHU Ge-li, ZHANG Yan-xia, BI Zhi-min, FENG Bao-hong. Effect of high glucose-based peritoneal dialysis fluids on NLRP3-IL-1β in human peritoneal mesothelial cells#br# [J]. Journal of Peking University(Health Sciences), 2017, 49(6): 954-960.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!